Table 3.
12 month outcomes of children with MDR TB
Baseline | 12-month follow-up | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Age (m) | Sex | HIV | Outcomes | WAZ-score | CD4 # | CD4% | WAZ-score | CD4 # | CD4% | RNA | |
1 | 2 | F | Neg | Lost to follow-up | -3.1 | ||||||
2 | 3.4 | M | Neg | Died 0.1 m | -3.9 | ||||||
3 | 3.8 | M | Neg | *MTBH 3 m | -0.5 | -1.6 | |||||
4 | 5.2 | M | Pos | Died 4.0 m | -1.8 | ||||||
5 | 11.9 | M | Neg | MTBH 6 m | -3 | -0.4 | |||||
6 | 18.5 | M | Neg | MTBH 6 m | -2 | -0.9 | |||||
Traced | |||||||||||
7 | 25 | M | Pos | Re-investigated | -2.3 | 264 | 23.2 | -3.1 | 297 | 21.7 | 5 |
8 | 29.2 | F | Neg | MTBH 6 m | -3.2 | -2 | |||||
9 | 62 | F | Pos | MTBH 7 m | -3.5 | 381 | 23.2 | -0.9 | |||
10 | 83.7 | F | Pos | MTBH 17 m | -3.5 | 105 | 5.1 | -2.1 | 285 | 11.1 | 4.7 |
11 | 96.7 | F | Pos | Died 1.8 m | -2.7 | 9 | 1.1 | ||||
12 | 144 | F | Pos | MTBH 12 m | -1 | 254 | 32 | -1.6 | 513 | 14.4 | 2.9 |
13 | 144 | M | Pos | Died 4.0 m | -2.4 | 36 | 2.2 |
*MTBH= MDR TB treatment facility